CONMED Corporation (CNMD) |
| 41.75 -0.66 (-1.56%) 07-14 16:00 |
| Open: | 41.37 |
| High: | 42.21 |
| Low: | 40.875 |
| Volume: | 0 |
| Market Cap: | 1,257(M) |
| PE Ratio: | 9.18 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 50.57 |
| Resistance 1: | 43.30 |
| Pivot price: | 35.71 |
| Support 1: | 35.97 |
| Support 2: | 31.44 |
| 52w High: | 56.64 |
| 52w Low: | 31.44 |
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
| EPS | 1.850 |
| Book Value | 33.760 |
| PEG Ratio | 1.84 |
| Gross Profit | 24.672 |
| Profit Margin (%) | 4.00 |
| Operating Margin (%) | 10.61 |
| Return on Assets (ttm) | 3.8 |
| Return on Equity (ttm) | 5.5 |
Tue, 14 Jul 2026
Needham Maintains ConMed(CNMD.US) With Hold Rating - Moomoo
Tue, 14 Jul 2026
Needham reiterates Hold on Conmed stock amid sale exploration By Investing.com - Investing.com UK
Mon, 13 Jul 2026
CONMED (CNMD) Stock Trades Up, Here Is Why - Yahoo Finance
Mon, 13 Jul 2026
Medtech Surges On Buyout Rumors; Who's Behind The Bid? - Investor's Business Daily
Mon, 13 Jul 2026
CONMED Up Over 10%, on Pace for Largest Percent Increase Since May 2025 -- Data Talk - Moomoo
Mon, 13 Jul 2026
CONMED (NYSE:CNMD) Sees Large Volume Increase - What's Next? - MarketBeat
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |